from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1339/-

LFCtreatmentdescriptionclass of inhibitor

2.034

Amikacinug/mL Amikacintranslation

0.689

Cap5-10ug/mL Capreomycintranslation

2.409

Rox10-50 ug/mL Roxithromycintranslation

0.371

SM2-5 ug/mL Streptomycintranslation

2.549

Tet5-10 ug/mL Tetracyclinetranslation

-0.073

Rif0.2-5ug/mL Rifampicintranscription

0.704

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.120

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.977

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.377

CPZ10-50 ug/mL Chlorpromazinerespiration

0.108

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.055

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.622

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.767

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.028

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.063

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.469

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.105

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.435

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.606

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.974

KCN5-20 ug/mL Potassium cyaniderespiration

0.067

NaN30.2-2 mM Sodium aziderespiration

-0.682

Nigericin50 uM Nigericinrespiration

-0.322

TRC10-150 ug/mL Triclosanrespiration

0.841

TRZ10-25 ug/mL Thioridazinerespiration

-0.531

Valinomycin0.5-10 uM Valinomycinrespiration

-0.431

ZnSO42 mM ZnSO4respiration

0.228

menadione6-10 ug/mL Menadionerespiration

0.038

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.228

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.197

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.213

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.192

NRP_1Non-replicating persistence stage 1dosRassociated

0.274

Amp0.2mg/mL AmpicillincellWall

-0.041

Cephalexin20-100 ug/mL CephalexincellWall

-0.135

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.581

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.054

EMB10-20 ug/mL EthambutolcellWall

0.676

Eta12-40 ug/mL EthionamidecellWall

1.815

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.002

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.358

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.743

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.963

BZA0.12 mg/mL BenzamidearomaticAmides

-0.961

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.665

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.036

H2O24 mM hydrogen peroxideDNAdamaging

-0.486

Levo10 ug/mL LevofloxacinDNAdamaging

-0.294

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.296

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.533

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.226

UVUV-irradiationDNAdamaging

1.832

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.752

Antimycin12.5-50 ug/mL Antimycin A?

-0.684

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.388

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.412

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.755

PA8240.2-2 ug/mL PA-824?

0.743

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.325

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.415

Verapamil50 uM Verapamil?

-0.276

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.615

methoxatin10-20 ug/mL Methoxatin?